Literature DB >> 21593405

Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury.

Sylvain Normand1, Anne Delanoye-Crespin, Aude Bressenot, Ludovic Huot, Teddy Grandjean, Laurent Peyrin-Biroulet, Yves Lemoine, David Hot, Mathias Chamaillard.   

Abstract

The colonic epithelium self-renews every 3 to 5 d, but our understanding of the underlying processes preserving wound healing from carcinogenesis remains incomplete. Here, we demonstrate that Nod-like receptor pyrin domain-containing protein 6 (NLRP6) suppresses inflammation and carcinogenesis by regulating tissue repair. NLRP6 was primarily produced by myofibroblasts within the stem-cell niche in the colon. Although NLRP6 expression was lowered in diseased colon, NLRP6-deficient mice were highly susceptible to experimental colitis. Upon injury, NLRP6 deficiency deregulated regeneration of the colonic mucosa and processes of epithelial proliferation and migration. Consistently, absence of NLRP6 accelerated colitis-associated tumor growth in mice. A gene-ontology analysis on a whole-genome expression profiling revealed a link between NLRP6 and self-renewal of the epithelium. Collectively, the integrity of the epithelial barrier is preserved by NLRP6 that may be manipulated to develop drugs capable of preventing adenoma formation in inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593405      PMCID: PMC3111299          DOI: 10.1073/pnas.1100981108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Authors:  Yee Hwa Yang; Sandrine Dudoit; Percy Luu; David M Lin; Vivian Peng; John Ngai; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Statistical issues in cDNA microarray data analysis.

Authors:  Gordon K Smyth; Yee Hwa Yang; Terry Speed
Journal:  Methods Mol Biol       Date:  2003

Review 3.  Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; Jean-Frederic Colombel; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2010-08-19       Impact factor: 5.325

4.  Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling.

Authors:  W Wu; A Glinka; H Delius; C Niehrs
Journal:  Curr Biol       Date:  2000 Dec 14-28       Impact factor: 10.834

5.  Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4.

Authors:  Bo Hu; Eran Elinav; Samuel Huber; Carmen J Booth; Till Strowig; Chengcheng Jin; Stephanie C Eisenbarth; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

Review 6.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation.

Authors:  Mohammad Hasan Zaki; Peter Vogel; Mathilde Body-Malapel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

8.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.

Authors:  Irving C Allen; Erin McElvania TeKippe; Rita-Marie T Woodford; Joshua M Uronis; Eda K Holl; Arlin B Rogers; Hans H Herfarth; Christian Jobin; Jenny P-Y Ting
Journal:  J Exp Med       Date:  2010-04-12       Impact factor: 14.307

9.  ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Authors:  Sung Hee Lee; Li-Li Hu; Jose Gonzalez-Navajas; Geom Seog Seo; Carol Shen; Jonathan Brick; Scott Herdman; Nissi Varki; Maripat Corr; Jongdae Lee; Eyal Raz
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

10.  VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer.

Authors:  Maximilian J Waldner; Stefan Wirtz; André Jefremow; Moritz Warntjen; Clemens Neufert; Raja Atreya; Christoph Becker; Benno Weigmann; Michael Vieth; Stefan Rose-John; Markus F Neurath
Journal:  J Exp Med       Date:  2010-11-22       Impact factor: 14.307

View more
  162 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

2.  The inflammasome: a remote control for metabolic syndrome.

Authors:  Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

Review 3.  Inflammasomes: far beyond inflammation.

Authors:  Jorge Henao-Mejia; Eran Elinav; Till Strowig; Richard A Flavell
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

Review 4.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.

Authors:  Hideki Hara; Sergey S Seregin; Dahai Yang; Koichi Fukase; Mathias Chamaillard; Emad S Alnemri; Naohiro Inohara; Grace Y Chen; Gabriel Núñez
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

Review 6.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

7.  The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.

Authors:  Tere M Williams; Rachel A Leeth; Daniel E Rothschild; Sheryl L Coutermarsh-Ott; Dylan K McDaniel; Alysha E Simmons; Bettina Heid; Thomas E Cecere; Irving C Allen
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 8.  Inflammasomes in intestinal inflammation and cancer.

Authors:  Grace Y Chen; Gabriel Núñez
Journal:  Gastroenterology       Date:  2011-10-15       Impact factor: 22.682

Review 9.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 10.  Regulation of intestinal microbiota by the NLR protein family.

Authors:  Amlan Biswas; Koichi S Kobayashi
Journal:  Int Immunol       Date:  2013-01-15       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.